1. Home
  2. TBI vs ACOG Comparison

TBI vs ACOG Comparison

Compare TBI & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

HOLD

Current Price

$4.59

Market Cap

129.9M

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$6.90

Market Cap

110.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TBI
ACOG
Founded
1985
2000
Country
United States
Canada
Employees
N/A
57
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
129.9M
110.4M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TBI
ACOG
Price
$4.59
$6.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$16.00
AVG Volume (30 Days)
305.8K
75.2K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
61.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.25
$139.22
Revenue Next Year
$3.90
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.18
$4.50
52 Week High
$7.78
$10.88

Technical Indicators

Market Signals
Indicator
TBI
ACOG
Relative Strength Index (RSI) 65.84 64.25
Support Level $4.57 $6.46
Resistance Level $5.56 $7.69
Average True Range (ATR) 0.29 0.57
MACD 0.12 0.07
Stochastic Oscillator 93.24 68.60

Price Performance

Historical Comparison
TBI
ACOG

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: